Join Dr Erin Vermaak, consultant rheumatologist, as she discusses PsO to PsA FAQs in this three part video series.

The aim of this video series is to understand the proportion of patients that will progress from PsO to PsA and the stages of progression, to explore treatment pathway from a rheumatologist’s perspective, and to identify treatment responses across both skin and joint symptoms in bio-naïve and TNF-experienced patients. 

For these materials CPD accreditation has been applied for. 

Presented by:
Dr Erin Vermaak

_{Date of preparation: June 2024 | IE-BK-2400338}

Bimzelx®▼ (bimekizumab) explored - A conversation with the experts

A series of 3 module videos discussing real world evidence with Bimzelx® (bimekizumab) in patients with psoriasis and psoriatic arthritis, including:

• The Journey from PsO to PsA: Exploring BIMZELX® (bimekizumab) in Skin and Joints
• BIMZELX® (bimekizumab) explored - A conversation with the experts Mr Emmanuel Toni and Dr Keith Wu
• BDNG Post Event 2023: Patient Case Studies

Presented by:
Dr Keith Wu

Mr Emmanuel Toni 

_{Date of preparation: November 2024 | IIE-BK-2400609}

 PASI 90 vs PASI 100: Implications for your patients video series 

A series of 4 module videos discussing real world evidence with Bimzelx®     (bimekizumab) in patients with psoriasis and psoriatic arthritis, including:

PASI 90 vs PASI 100 data 

Patient case studies 

Implications for your patients 

Presented by:

Dr Kave Shams 

Date of preparation: November 2024 | IE-BK-2400611